Inici › Colitis ulcerosa › Texas › San Antonio
Assaigs clínics de Colitis ulcerosa a San Antonio, TX
16 estudis de Colitis ulcerosa busquen participants en centres de San Antonio i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ReclutantFase 3
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
ReclutantFase 2
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
ReclutantFase 1/2Voluntaris sans benvinguts
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ReclutantFase 2
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutantFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
ReclutantFase 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
ReclutantFase 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
ReclutantFase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ReclutantEstudi observacional
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
Assaigs de Colitis ulcerosa en altres ciutats
- New York City, NY23 estudis
- Orlando, FL22 estudis
- Miami, FL21 estudis
- Houston, TX17 estudis
- Tacoma, WA15 estudis
- Chicago, IL15 estudis
- San Diego, CA15 estudis
- Tyler, TX14 estudis
- Colorado Springs, CO14 estudis
- Los Angeles, CA13 estudis
- St. Louis, MO13 estudis
- Washington, DC12 estudis
Altres estudis a San Antonio
- Càncer de pulmó de cèl·lules no petites59 estudis
- Càncer colorrectal46 estudis
- Càncer de mama46 estudis
- Càncer metastàtic44 estudis
- Càncer (tots els tipus)41 estudis
- Obesitat40 estudis
- Diabetis tipus 237 estudis
- Sobrepès34 estudis
- Càncer d'ovari31 estudis
- Càncer de pàncrees31 estudis
- Càncer de pròstata28 estudis
- Càncer d'endometri27 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.